Gastric Cancer
Studies from D.K. Sohn and colleagues yield new information about gastric cancer
Published in Oncology Business Week, September 21st, 2008
"A submucosal injection of sodium hyaluronate is widely used for mucosal elevation in endoscopic mucosal resection (EMR) or endoscopic submucosal dissection procedures; however, the oncologic safety of sodium hyaluronate remains unknown. Hyaluronate is the main ligand for CD44 and this interaction was reported to promote tumor progression in in vitro or animal studies," scientists writing in the Journal of Gastroenterology and Hepatology report.
"This study aimed to evaluate the effects of sodium hyaluronate on tumor growth after EMR for gastrointestinal cancers. The study included 18 consecutive patients who underwent surgery for locally-recurrent or remnant...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Accuray Incorporated
Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO - Affymetrix Inc.
Affymetrix Launches 3' IVT Express Kit for Faster, More Reliable Target Preparation - Alzheimer Disease
Anavex completes successful preclinical studies on lead Alzheimers drug candidate - Anadis Ltd.
Clinical Trial Protocol Against Cancer Therapy Side Effects Mucositis Approved - Applied Biosystems Inc.
Applied Biosystems Teams With Leaders in Connecticut and New Jersey to Drive Stem Cell Research - Arizona Heart Institute
LifeGuard Established at the Arizona Heart Institute - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
